Dachaigh › Easbhaidh Alpha-1 Antitrypsin › South Carolina
Sgrùdaidhean clionaigeach Easbhaidh Alpha-1 Antitrypsin ann an South Carolina
Tha 6 sgrùdaidhean airson Easbhaidh Alpha-1 Antitrypsin a’ lorg phàirtichean aig làraichean ann an South Carolina.
Bailtean ann an South Carolina
Teacsa sgrùdaidh oifigeil (Beurla)
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
- Clinical Study Center, Charleston
A’ fastadhÌre 1/2
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT06389877A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
- Clinical Study Center, Charleston
A’ fastadhÌre 1/2
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT07227207A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 101, Charleston
A’ fastadhÌre 3
Aoisean 18 gu 80 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT07555483A Study in Adults to Learn About Inherited Alpha-1 Antitrypsin Deficiency (AATD) and AATD Related Liver Problems
- University of South Carolina, Charleston
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Iuch 2026 · NCT06512454Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Medical University of South Carolina, Charleston
A’ fastadhÌre 3
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 13 Cèit 2026 · NCT05677971A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
- Medical University of South Carolina, Charleston
A’ fastadhÌre 1
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 22 Iuch 2025 · NCT06049082Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.